The explanation of this phenomenon was, that HER2-negative IDCs might not derive from DCIS, but develop from another lesion, the atypical ductal hyperplasia (ADH), which showed no HER2 amplification (Menard et al, 2001). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.